
Beyond the Pay Ratio: What Integer Holdings' Executive Compensation Reveals About Medical Device Manufacturing's New Reality
Beyond the Pay Ratio: What Integer Holdings' Executive Compensation Reveals About Medical Device Manufacturing's New Reality
The Headline Numbers: A Snapshot of Pay at a Pivotal Moment
Integer Holdings Corporation’s 2024 executive compensation disclosure provides a quantitative snapshot of a year defined by leadership transition. The data reveals a median employee pay of $78,534 (Source 1: [Primary Data]). The resulting CEO-to-median-employee pay ratio stands at 58:1. This ratio is derived from the total 2024 compensation of $4,559,000 for Joseph Dziedzic, who served as CEO until February 1, 2024 (Source 1: [Primary Data]; Source 2: [Primary Data]). His successor, Jason Garland, received total compensation of $3,238,000 for the year (Source 1: [Primary Data]). These figures are set against the company’s operational scale, with annual revenue reported at $1.86 billion (Source 1: [Primary Data]). The disclosure functions as a financial report card for a period where executive stewardship changed hands.
Decoding the CEO Pay Drop: Transition Strategy or Market Correction?
The year-over-year change in CEO compensation is the most volatile element in the dataset. Joseph Dziedzic’s total pay decreased by approximately 46%, from $8,397,000 in 2023 to $4,559,000 in 2024 (Source 1: [Primary Data]). This decline is not indicative of a broad-based reduction. Compensation for other Named Executive Officers remained within a stable band of $1.4 million to $1.9 million (Source 1: [Primary Data]). The structure of Dziedzic’s 2024 package, likely finalized upon his transition from the CEO role, reflects a common recalibration following a leadership change, often involving the vesting of long-term awards and a shift in role-based incentives.
Jason Garland’s inaugural compensation package of $3.24 million establishes a new baseline. This figure represents the board’s valuation of the CEO role in the current market for a medical device contract manufacturing leader. The significant differential between Dziedzic’s 2023 peak and Garland’s 2024 starting point suggests a strategic reset. It may reflect a board-level adjustment to align pay with a new phase of corporate strategy or a response to evolving investor governance pressures concerning post-transition pay structures.
The 58:1 Ratio in Context: Not Just a Number, but an Industry Diagnostic
The 58:1 pay ratio is a diagnostic tool specific to Integer’s operational model. Compared to the S&P 500 median, which frequently exceeds 200:1, Integer’s ratio is moderate. This moderation is structurally linked to the fundamentals of medical device contract manufacturing. The business is capital-intensive and relies on a large, skilled workforce of engineers, technicians, and precision manufacturing specialists. The reported median wage of $78,534 is consistent with the compensation required to retain such technical talent in a competitive labor market. Consequently, the denominator in the pay ratio is inherently elevated compared to industries with more retail or unskilled labor forces, or those like software where high profitability can be generated by a relatively small employee base.
The stability of the median wage, juxtaposed with the volatility in CEO pay, indicates distinct pressures on different segments of the workforce. For the median employee, compensation is governed by tight labor markets for specialized skills and the operational necessity of low turnover. For the CEO, compensation is subject to the discrete events of succession planning, long-term performance award cycles, and board-level strategy shifts.
Governance and Strategy: Reading Between the Lines of the Proxy Statement
The compensation data elucidates governance priorities during a transitional year. The board’s decisions manifest a bifurcated approach: maintaining stability within the broader executive team while managing a deliberate reset at the very top. This pattern suggests that the leadership transition was planned and executed without signaling broader operational instability, as evidenced by the consistent pay ranges for other executives.
The compensation structure for the new CEO will be the more critical indicator of long-term strategic direction. The composition of Garland’s $3.24 million package—the balance between salary, annual bonus, and long-term equity incentives—will reveal the board’s emphasis on short-term execution versus multi-year growth targets. In a sector where manufacturing excellence, supply chain reliability, and R&D partnership are critical, incentive metrics likely focus on operational efficiency, margin expansion, and strategic account growth rather than purely stock price appreciation.
Implications for the Sector: A Bellwether for Contract Manufacturing
Integer Holdings’ disclosure serves as a bellwether for the medical device contract manufacturing sector. The data underscores several industry realities. First, competitive median wages are a fixed cost of doing business, essential for quality and innovation. Second, executive compensation in this space, while substantial, appears tempered relative to pure-play pharmaceutical or technology innovators, reflecting the sector’s different margin profile and growth expectations. Third, leadership transitions can cause significant but temporary volatility in top-tier pay figures, which may not correlate directly with overall company performance or employee experience.
The trajectory of the median wage will be a key metric to monitor. Sustained increases could signal successful scaling and premium talent acquisition. Stagnation, however, could indicate margin pressure or a strategic shift toward automation, potentially altering the employee composition and, subsequently, the pay ratio itself.
Conclusion: A Quantified Transition in a Demanding Landscape
The 2024 executive compensation disclosure from Integer Holdings transcends a regulatory requirement. It provides a quantified narrative of a company navigating a CEO transition within the complex landscape of advanced manufacturing. The sharp decline in the former CEO’s pay, the establishment of a new CEO pay benchmark, and the stable, skilled median wage collectively paint a picture of an organization in a period of deliberate recalibration. The relatively moderate 58:1 pay ratio is less a statement on equity and more a direct function of the company’s labor-intensive, high-skill business model. For investors and industry observers, these figures offer a baseline. The evolution of this compensation architecture in the coming years will reveal how Integer’s governance adapts to the dual challenges of rewarding leadership for growth and retaining the technical workforce that makes such growth possible.